SensoDetect AB (XSAT:SDET) Total Assets: kr15.71 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is SensoDetect AB Total Assets?

SensoDetect AB XSAT:SDET -27.27% Total Assets is kr15.71 Mil as of Mar. 2026. The stock has 2 warning signs investors should review.

SensoDetect AB's Total Assets for the quarter that ended in Mar. 2026 was kr15.71 Mil.

During the past 12 months, SensoDetect AB's average Total Assets Growth Rate was 40.20% per year. During the past 3 years, the average Total Assets Growth Rate was 25.90% per year. During the past 5 years, the average Total Assets Growth Rate was 8.10% per year. During the past 10 years, the average Total Assets Growth Rate was 14.80% per year.

During the past 13 years, SensoDetect AB's highest 3-Year average Total Assets Growth Rate was 47.10%. The lowest was -17.00%. And the median was 14.10%.

Total Assets is connected with ROA %. SensoDetect AB's annualized ROA % for the quarter that ended in Mar. 2026 was -46.18%. Total Assets is also linked to Revenue through Asset Turnover. SensoDetect AB's Asset Turnover for the quarter that ended in Mar. 2026 was 0.08.

SensoDetect AB  (XSAT:SDET) Total Assets Explanation

Total Assets is connected with ROA %.

SensoDetect AB's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-7.444/( (16.53+15.709)/ 2 )
=-7.444/16.1195
=-46.18 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

SensoDetect AB's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=1.303/( (16.53+15.709)/ 2 )
=1.303/16.1195
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

SensoDetect AB Total Assets Related Terms

SensoDetect AB Total Assets Historical Data

* Premium members only.

The historical data trend for SensoDetect AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SensoDetect AB Total Assets Chart

SensoDetect AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.56 8.46 25.29 17.41 16.53

SensoDetect AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.81 20.60 18.61 16.53 15.71

SensoDetect AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

SensoDetect AB's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=12.969+3.561
=16.53

SensoDetect AB's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=11.103+4.606
=15.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of kr15.71 Mil mean?
SensoDetect AB (XSAT:SDET) has a Total Assets of kr15.71 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on SensoDetect AB and its competitors.
Is SensoDetect AB's Total Assets too high?
SensoDetect AB's current Total Assets is kr15.71 Mil.
How does SensoDetect AB's Total Assets compare to ABT and SYK?
SensoDetect AB's Total Assets of kr15.71 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on SensoDetect AB and its competitors. SensoDetect AB's current Total Assets is kr15.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SensoDetect AB stock overvalued right now?
SensoDetect AB (XSAT:SDET) has a current Total Assets of kr15.71 Mil. The current Total Assets is kr15.71 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For SensoDetect AB (XSAT:SDET), the current Total Assets is kr15.71 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SensoDetect AB Business Description

Address Hyllie Stationstorg 31, floor 7, Malmo, SWE, 215 32
SensoDetect AB is a Sweden based company engaged in providing solutions for mental illness. It offers a SensoDetect Brainstem Evoked Response Audiometry, which is a method of stimuli and measurement of brainstem activity, helping to increase efficiency within psychiatry and thereby the benefits for healthcare, society, patients and relatives.